Update on the Canadian Diabetes Association 2008 clinical practice guidelines.
作者信息
Bhattacharyya Onil K, Estey Elizabeth A, Cheng Alice Y Y
机构信息
Li Ka Shing Knowledge Institute of St Michael's Hospital in Toronto, Ont.
出版信息
Can Fam Physician. 2009 Jan;55(1):39-43.
Abstract
摘要
相似文献
1
Update on the Canadian Diabetes Association 2008 clinical practice guidelines.
Can Fam Physician. 2009 Jan;55(1):39-43.
2
[New studies, new strategies, new guidelines: so that diabetic patients will live longer].
MMW Fortschr Med. 2005 Oct 13;147(41):4-6.
3
Importance of glycemic control.
J Fam Pract. 2011 Sep;60(9 Suppl):S4-6.
4
The management of type 2 diabetes mellitus focus on quality.
Prim Care. 2007 Mar;34(1):1-38. doi: 10.1016/j.pop.2007.01.001.
5
Type 2 diabetes: target HbA1c of about 7%.
Prescrire Int. 2009 Aug;18(102):177.
6
Higher type 2 diabetes-related mortality when HbA1c levels are too low.
Prescrire Int. 2008 Oct;17(97):213.
7
Cardiovascular disease and intensive glucose control in type 2 diabetes mellitus: moving practice toward evidence-based strategies.
Vasc Health Risk Manag. 2009;5:859-71. doi: 10.2147/vhrm.s4808. Epub 2009 Nov 2.
8
Diabetes: glycated hemoglobin is a marker of diabetes and CVD risk.
Nat Rev Cardiol. 2010 Jul;7(7):367-8. doi: 10.1038/nrcardio.2010.84.
9
Safety of very tight glucose control in type 2 diabetes in question.
Diabetes Obes Metab. 2008 May;10(5):438. doi: 10.1111/j.1463-1326.2008.00906.x.
10
Is Hemoglobin A1c the Right Outcome for Studies of Diabetes?
JAMA. 2017 Mar 14;317(10):1017-1018. doi: 10.1001/jama.2017.0029.
引用本文的文献
1
Depression scores and its relationship with sexual quality of life in women with type 1 and type 2 diabetes: A cross-sectional study.
Medicine (Baltimore). 2024 Aug 9;103(32):e38641. doi: 10.1097/MD.0000000000038641.
2
Endometriosis increases the risk of gestational diabetes: a meta-analysis stratified by mode of conception, disease localization and severity.
Sci Rep. 2023 May 19;13(1):8099. doi: 10.1038/s41598-023-35236-y.
3
Treatment pattern trends of medications for type 2 diabetes in British Columbia, Canada.
BMJ Open Diabetes Res Care. 2022 Nov;10(6). doi: 10.1136/bmjdrc-2022-002995.
4
Diabetes Risk Assessment and Awareness in a University Academics and Employees.
Sisli Etfal Hastan Tip Bul. 2021 Dec 29;55(4):524-531. doi: 10.14744/SEMB.2021.84770. eCollection 2021.
5
Assessment of an Interactive Digital Health-Based Self-management Program to Reduce Hospitalizations Among Patients With Multiple Chronic Diseases: A Randomized Clinical Trial.
JAMA Netw Open. 2021 Dec 1;4(12):e2140591. doi: 10.1001/jamanetworkopen.2021.40591.
6
Detecting cord blood cell type-specific epigenetic associations with gestational diabetes mellitus and early childhood growth.
Clin Epigenetics. 2021 Jun 26;13(1):131. doi: 10.1186/s13148-021-01114-5.
7
Impact of the diabetes Canada guideline dissemination strategy on dispensed vascular protective medications for older patients in Ontario, Canada: a linked EMR and administrative data study.
BMC Health Serv Res. 2020 May 1;20(1):370. doi: 10.1186/s12913-020-05232-3.
8
Metformin and endometrial cancer survival: a quantitative synthesis of observational studies.
Oncotarget. 2017 Aug 2;8(39):66169-66177. doi: 10.18632/oncotarget.19830. eCollection 2017 Sep 12.
9
Do We Need Updated Guidelines on the Use of Insulin Pump Therapy in Type 2 Diabetes? A Review of National and International Practice Guidelines.
J Diabetes Sci Technol. 2016 Nov 1;10(6):1388-1398. doi: 10.1177/1932296816667747. Print 2016 Nov.
10
Five-year change of clinical and complications profile of diabetic patients under primary care: a population-based longitudinal study on 127,977 diabetic patients.
Diabetol Metab Syndr. 2015 Sep 17;7:79. doi: 10.1186/s13098-015-0072-x. eCollection 2015.
本文引用的文献
1
10-year follow-up of intensive glucose control in type 2 diabetes.
N Engl J Med. 2008 Oct 9;359(15):1577-89. doi: 10.1056/NEJMoa0806470. Epub 2008 Sep 10.
2
Effects of intensive glucose lowering in type 2 diabetes.
N Engl J Med. 2008 Jun 12;358(24):2545-59. doi: 10.1056/NEJMoa0802743. Epub 2008 Jun 6.
3
Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes.
N Engl J Med. 2008 Jun 12;358(24):2560-72. doi: 10.1056/NEJMoa0802987. Epub 2008 Jun 6.
4
Telmisartan, ramipril, or both in patients at high risk for vascular events.
N Engl J Med. 2008 Apr 10;358(15):1547-59. doi: 10.1056/NEJMoa0801317. Epub 2008 Mar 31.
5
Effect of a multifactorial intervention on mortality in type 2 diabetes.
N Engl J Med. 2008 Feb 7;358(6):580-91. doi: 10.1056/NEJMoa0706245.
6
Predicted quality-adjusted life years as a composite measure of the clinical value of diabetes risk factor control.
Med Care. 2007 Apr;45(4):315-21. doi: 10.1097/01.mlr.0000254582.85666.01.
7
Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study.
Lancet. 2006 Jul 1;368(9529):29-36. doi: 10.1016/S0140-6736(06)68967-8.
8
Recent trends in cardiovascular complications among men and women with and without diabetes.
Diabetes Care. 2006 Jan;29(1):32-7. doi: 10.2337/diacare.29.01.06.dc05-0776.
9
Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins.
Lancet. 2005 Oct 8;366(9493):1267-78. doi: 10.1016/S0140-6736(05)67394-1. Epub 2005 Sep 27.
10
Clinical outcomes in antihypertensive treatment of type 2 diabetes, impaired fasting glucose concentration, and normoglycemia: Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT).
Arch Intern Med. 2005 Jun 27;165(12):1401-9. doi: 10.1001/archinte.165.12.1401.
Zotero 插件